Antithrombin IIi and heparin cofactor Ii
Kondo, S.; Niwa, M.
Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 61: 106-113
1985
ISSN/ISBN: 0047-1860 PMID: 3839027 Document Number: 242956
Document emailed within 1 workday
Related Documents
Scully, M.F.; Ellis, V.; Kakkar, V.V. 1986: Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation Thrombosis Research 41(4): 489-499Zhang, L.; Zhang, G. 1999: Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity Hunan Yi Ke da Xue Xue Bao 24(4): 309
Akai, Y.; Shiga, S.; Tohyama, K.; Shimatsu, A.; Ichiyama, S. 2000: Effect of heparin cofactor Ii on the antithrombin IIi activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women Rinsho Byori. Japanese Journal of Clinical Pathology 48(9): 867-871
Levy, S.W.; Jaques, L.B. 1978: Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis Thrombosis Research 13(3): 429-441
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Sie, P.; Boneu, B. 1987: The other heparin cofactor Presse Medicale 16(4): 149-150
Pál, A.; Sas, G. 1990: Heparin cofactor Ii studies in thrombophilic patients Orvosi Hetilap 131(9): 461
Tollefsen, D.M. 1995: Insight into the mechanism of action of heparin cofactor Ii Thrombosis and Haemostasis 74(5): 1209-1214
Rossi, E.B.; Duboscq, C.L.; Kordich, L.C. 1999: Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role Medicina 59(1): 95-104
Mackie, I.J.; Segal, H.; Burren, T.; Gallimore, M.; Walshe, K.J.; Robinson, G.; Machin, S.J. 1990: Heparin cofactor Ii levels are increased by the use of combined oral contraceptives Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(6): 647-651
Grau, E.; Oliver, A.; Félez, J.; Barceló, P.; Fernandez, C.; Ballarin, J.A.; Fontcuberta, J.; Rutllant, M.L. 1988: Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome Thrombosis and Haemostasis 60(2): 137-140
Lopaciuk, S.; Bykowska, K.; Kopeć, M. 1996: Prevalence of heparin cofactor Ii deficiency in patients with a history of venous thrombosis Polish Journal of Pharmacology 48(1): 109-111
Shiba, T.; Takeuchi, S.; Awazu, S.; Igarashi, M.; Asada, T. 1978: Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(3): 560-563
Hayashi, T.; Sakuragawa, N. 1992: Heparin cofactor Ii inhibits thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 92: 201-206
Nakagawa, M.; Okada, T.; Okuda, S.; Nishizawa, A.; Watada, M. 1977: Exogenous heparin and antithrombin activity Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 40(2): 207-212
Mach, U.; Puzyna, W. 1987: Effect of heparin treatment on antithrombin IIi (AT III) activity Ginekologia Polska 58(8): 544-547
Aiach, M.; Fiessinger, J.N.; Andreux, J.P.; Beuvin, J.; Housset, E.; Leclerc, M. 1977: Electrophoretic mobility of antithrombin IIi in an agarose gel with heparin Pathologie-Biologie 25 Suppl: 35-41
Riensenfeld, J.; Höök, M.; Björk, I.; Lindahl, U.; Ajaxon, B. 1977: Structural requirements for the interaction of heparin with antithrombin IIi Federation Proceedings 36(1): 39-43
Koike, C.; Hayakawa, Y.; Niiya, K.; Sakuragawa, N.; Sasaki, H. 1996: The production of heparin cofactor II is not regulated by inflammatory cytokines in human hepatoma cells: comparison with plasminogen activator inhibitor type-1 Thrombosis and Haemostasis 75(2): 298-302